Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CytoDyn's new management is, indeed, quite new. Didn't expect immediate change (in spite of the initial "goodwill" sp rise), it's going to take some time for Cyrus Arman to - really- get in the game as he only recently immersed himself "in the CytoDyn pool" in mid-July.
And because of potential resistance from BP and more pointed obstructionism via BP's marionette >> the FDA, Arman must be careful not to telegraph his moves.
Still, it looks like the decks have been cleared for action (people, product, vectors overboard), some ammunition (in the form of shares) has been taken on, and now we have to be patient.
President Arman has a powerful, though to BP - potentially scary - product, with a unique MOA and plenty of potential applications individually and as an adjuvent. Let's see if he can surprise everyone with some astute "moves."
The game has yet to begin. Hopefully President Arman will impress us with his acumen and adroit strategy(s).
In the meantime, I'm pleased current CYDY bigwigs are being remunerated in shares - definitely keeps them on their toes and in the game.
Looking forward to some pleasant surprises.
IMO
The setting is all-important and quite relevant. It appears the CDC is taking the position: "Covid" is endemic and "citizens will have to live with it." Or die with it - as they're blithely ignoring almost 500 succumb daily to its razor sharp scythe.
The message seems to be. "accept the possibility of death or disability (via PASC), just be grateful for the vaccines as we hand them out and muddle on."
And now the cold weather approaches. Meanwhile, just over the horizon, the horsemen of the apocalypse ready their steeds preparing to wreak havoc once again. Too bad because a combination of CytoDyn's Leronlimab and Todos' Tollovir could change the picture, but it would puncture the
MIGHTY BP VACCINATION BLIMP AND "FOREVER" INCOME SCHEME.
A number of tragic elements are about to coalesce.
Stay safe my fellow longs >> this could be a looooong winter.
IMO
Yes, it's time to accomplish more than providing golden chariots for CytoDyn "Executives."
They've got a seriously versatile drug with a unique MOA, numerous applications and an extraordinary safety record. It's time to do something for the shareholders. If this crew can't get it done - let's get some folks that can.
Before covid takes us all away...
Imo
Sorry can't be very helpful as per your request. I'm a buy and hold - don't have the luxury to monitor movement in real time.
Good luck though.
Welcome Leeroy,
Leronlimab is a monoclonal antibody that has a unique Mechanism of Action (MOA). One of it's key functions targets the CCR5 receptor. This particular receptor is very important in a number of diseases/conditions/afflictions. For example: "the CCR5 receptor, has been implicated in multiple disease processes from HIV, GvHD, NASH, stroke recovery, multiple sclerosis, COVID-19, NAFLD/NASH, to metastatic cancer. Leronlimab, our CCR5 antagonist, is a once-a-week, subcutaneous injection. One molecule with multiple opportunities."
Yes, it has not been a "free-ride," but one made especially difficult by "Big Pharma" and its minions. Leronlimab has only exhibited minor negative side effects (if any), appears to be capable to crossing the Blood/brain/barrier, is a key controlling agent when it comes to inflammation associated with CCR5, but Leronlimab also poses a significant threat to many current and future Pharma product lines. For this reason, Cytodyn and it's drug Leronlimab (aka Vyrologix aka Pro 140) has had a very difficult journey, but new leadership and a bit of dilution (to create a pool of funding) will hopefully allow this drug to "break through."
Finally, I want this drug to "break through" and become available. It has the potential to play a positive role in the lives of many, has already saved numerous lives, it's time to allow it to save many more and/or improve the quality of life for the afflicted.
So take a look at >> Leronlimab << the drug that might eventually rival penicillin in its revolutionary possibilities.
Welcome
(In My Humble Opinion)
Welcome Leeroy, Leronlimab is a monoclonal antibody that has a unique Mechanism of Action (MOA). One of it's key functions targets the CCR5 receptor. This particular receptor is very important in a number of diseases/conditions/afflictions. For example "the CCR5 receptor, has been implicated in multiple disease processes from HIV, GvHD, NASH, stroke recovery, multiple sclerosis, COVID-19, NAFLD/NASH, to metastatic cancer. Leronlimab, our CCR5 antagonist, is a once-a-week, subcutaneous injection. One molecule with multiple opportunities."
There are a number of people here that could give you great explanations: Here are a few "handles" that would be helpful: Misiu143, Hookmeistr, Evil Rabbit, Monroe1, Chuckles759, daemon57, JPG77, and plenty more that have "weathered the storms" that Cytodyn's Leronlimab has been subjected to.
Yes, it has not been a "free-ride," but one made especially difficult by "Big Pharma" and its minions. Leronlimab has only exhibited minor negative side effects (if any), appears to be capable to crossing the Blood/brain/barrier, is a key controlling agent when it comes to inflammation associated with CCR5, and poses a significant threat to many current and future Pharma product lines. For this reason Cytodyn and it's drug Leronlimab (aka Vyrologix aka Pro 140) has had a very difficult journey, but new leadership and a bit of dilution (to create a pool of funding) will hopefully allow this drug to "break through."
Finally, I want this drug to "break through" and become available. Its potential will affect people you know and/or care about...and perhaps you. It has already saved numerous lives, it's time to allow it to save many more and/or improve the quality of life for those afflicted.
So it appears, you've opened the door to >> Leronlimab << the drug that might eventually rival penicillin in its mind-numbing possibilities.
Welcome...come on in and take a look around!
In My Humble Opinion
A question: Does BP really want to kill the golden (viral) goose?
End the virus = ending the endlessly recurring yearly (or more) vax jackpot.
...And any junior executive excitedly waving a vial of the ultimate answer will find their career at an end.
Not good for the bottom line
The end.
(In my opinion)
[Put that stuff in the basement fridge. We can pull it out in the event someone else field's a cure...hold them up a bit and beat them to the punch. Ahhhh, but we'll miss the good ole days!)
A thought..."Tollo" addressing the 3CL suddenly generates "light at the end of the tunnel."
The current strategy addressing Covid is deeply flawed! Vaccines guarantee >>> what?
*You will not contract "Covid" >>>>>>NO
*You can not infect others >>>>>>>>NO
*You will not be hospitalized>>>>>>>NO
(There's a lot of hemming and hawing saying it will probably, maybe, hopefully, perhaps keep you from getting severe or critical cases of "Covid.")
What's wrong with this picture? The Covid is allowed to flourish. It can pack its little covid-bags and travel throughout the world, infecting at will! AND if virus hits the jackpot - it might generate a variant that really kicks some butt. Like myriad tiny gambling maniacs maddly pulling on the one-armed bandit...trying to arrive at the perfect combination of mutations.
Then one day the lights flash, balloons and confetti fill the air as viral music blares in celebration - the jackpot has been hit! Better duck.
See more at post 10546.
My Opinion!
Also congratulations on having a successful surgical encounter! ...And may you remain in good health!
JFB - Check and checkmate, nicely done!
I think GC's Tollo-family is a seriously effective response to a Covid/or similarly performing viral incursion. I've been taking it for months and have nothing really negative to say about it. In fact, I suspect it may have "put a damper" on some other minor "situations" which surprisingly resolved. Could have been a coincidence, but...I'm not complaining. If these are the "side-effects" I'll keep taking it (was planning to anyway).
Strictly my opinion/experience
Monroe, agreed - treat Covid like strep throat. If one feels sickly, tests positive, gets first shot of leronlimab and starts pounding down Tollovid (or - Tollovir when it finally gets the nod) while isolating. [This isolation must be mandatory and enforced!]
Leronlimab locks off the CCR5 entry points while the Tollovid puts a lid on the 3CL ramping up. Meanwhile, the recipient of Covid isolates until two tests 24 hrs apart are "clean"(?). And the recipient receives a weekly injection of leronlimab for a minimum of four shots or until the physician feels the Covid infection and Long-term Covid threat has diminished.
Let's see...With the vax one might still get covid, spread covid, allow covid to continue mutating and prolong the entire affair (AND some even die > in spite of having the vax)! In effect - "current procedure keeps the 'Covid ball' rolling." Not isolating and allowing the virus to spread, mutate and come back again is trashing our economy and foments cyclical massive disruption.
It's imperative to stop the covid spread, shut this disease DOWN! and vax doesn't do it...in fact...it appears to prolong Covid's existence while giving the Covid rein to create new and potentially more deadly variants... so just what does vax do? >>> oh, I forgot >>> it prints money...yeah got to remember the mission!
Sap, obviously a profound sense of humor - except ED isn't something often bragged about, nor a "laughing matter" to those so affected. It appears Long Covid can have a deleterious effect resulting in ED.. This IS a much bigger concern than some, obviously, realize. The revelation that Tollovid may restore function is BIG. Once word spreads, expect to see sales generated by this revelation.
For "edification" kindly peruse the recent article below:
The Viagra for Long Covid (appears long covid can increase chance of Erectile Dysfuncion by a factor of three)
2022 May 28
https://www.zerohedge.com/news/2022-05-28/viagra-long-covid
IMO
Personal animus with "NP" should be directed AT THE SOURCE of displeasure. NP is a stockholder (assumedly), and has the same rights and privileges as other stock holders. Perhaps a challenge to a game of chess, darts, Go, etc., since dueling pistols are out of fashion and more trouble than they're worth. Just keep in mind...YOU could easily come out the "lesser."
I believe moving forward is a more opportune path. Leronlimab is still standing. In fact, STANDING TALL!
It's like leronlimab, as represented by the gems secreted in Marco Polo's garments as he returned to a changed world after his years in the far east. We have Leronlimab - more than the equivalence of Marco's gems. We just have to "broker a few stones" to get things rolling....
Still long and optimistic
IN FACT - Leronlimab's the drug I want available NOW. It's one (since relatively harmless) I'd use to address some common "aging issues." Guess what's going to happen when this stuff finally gets approved. Lot's of folks are going to want to "try" it. And it will be fueled by many actually finding some relief (or the belief they did).
all My opinion
Destroyed Leronlimab's value? >if anything it's enhancedy. If the CCR5 receptor plays a key role in the insult/condition/affliction Leronlimab is the first choice. Its trials' "near misses" weren't due to Leronlimab (yes there is a limited number that LL doesn't help, but at the same time - it doesn't pose the risks of most drugs available). Astute observers understand this.
Don't get lost in the "razzle dazzle," but the meta view of Leronlimab suggests a game-changer. This drug is not alone, others are being "investigated" as possibilites in the quest for life extension. Most are keenly aware of the past, which has value. But if you want a peek into the future, check out the work of David Sinclair and others.
Hit it big with Leronlimab and you too might reap the benefits of Sinclair (and others) research/advances.
IMO
Been watching more than posting lately. Interestingly,
The REALITY IS
Leronlimab poses a challenge that threatens a number of current and potential product lines. We're talking a drug, (leronlimab) with minimal side effects and being a primary "actor," or part of a therapy...shows efficacy in numerous areas (AND IT APPEARS >>>>including the blood-brain-barrier). Forget the stock's current value...The question is what's the sale price for HOPEFULLY ONLY A PIECE OF THE PIE!
This Leronlimab has TOOOOOOOO many potential applications due to its MOA.
That's why, I hope they're just sellin' a piece of the pie!
Long hauler's alone is an enviable market.
Cancer WOW >>> DOUBLE WOW
Facing Covd-19 >> It's shown its ability to be the last thing to try ( for those nearly dying), but isn't that stupid - when it should be the first -- I think Leronlimab with the extra "jolt" of Tollovir would be a virus slamming item AND if the user runs the course of the meds - a greatly lessened occurrence of PASC (Long-Haulers' Syndrome)..
NASH >>>>>>More WowS
and due to Leronlimab's MOA > primary or secondary (or /with) efficacy.
And may help address what we call inflammatory situations elsewhere.
And it won't kill me!
If I get covid I want a Leronlimab cocktail, on ice, with a tiny umbrella?
(Unfortunately, there doesn't appear to be edible form of leronlimab...yet. Please make it palatable!)
Here's a thought - First we have to make sure that tollovir and leronlimab are safe to use in unison.
But THAT would be a substantial (temporary*) wall to the virus/ If done in a coordinated way throughout the world
it could be
successful
but
consider
the
yearly
vaccination
revenue
lost
let's not be hasty...
These two drugs (Todos' Tollovir and CytoDyn's Leronlimab 4 wks min- if widely distributed simultaneously "used" might halt the threat of Covid-19.
But this should consist of several steps - the first being - are these two drugs compatible and at what strengths should they be utilized? Stage (and other factors)- appropriate dosing.
I'm tired of being separate from those I love and enjoy. I want Leronlimab readily available and at first proof of covid - I also want Todos' Tollovir to halt the vial replication process and assist in inhibition of 3CL effects within the cell including the role of interfering with viral replication and an immunomodulatory role.
bottom line
Piecing out some of our prizes...
Give them NASH and keep Long Haulers' Syndrome (PASC)
(Why to keep PASC! - so many of the manifestations that mimic other "maladies.." If Leronlimab works for "brain fog" for PASC folks...what might it do for normal folks? This and other "manifestations of PASC" create numerous markets (think of the 18 areas on the first Long Haulers' trial that showed significant success - each more than a dollar sign). These are things that "bother people" and Leronlimab might have utility in more areas than originally conceived.
Stuff doesn't seem to have much risk at all... But all of this is JUST MY OPINION.
Forgot about HIV -- it's good too!
It is, indeed, fortuitous that this board isn't the only arena of import. Swords crossed here have limited import and a waste of momentum. Take the "burn" in support of Leronlimab and find an audience.
Meanwhile, leronlimab is independent of the turmoil surrounding it! It will do its "Leronlimab thing" and it doesn't appear to elicit severe reactions in the process. It either helps or it doesn't, but its use (unlike several others). doesn't leave users with potentially long-lasting to permanent damage.
Working against this drug, in my opinion, is like discarding all fire alarms and fire extinguishers. Because when one's time comes...and it's the right answer...it better be there...or
IMO
Stop the burial- this patient's far from dead!
This isn't the scene of a tragedy, not while we still own all the rights to Leronlimab. I'm sure there are some gleefully snickering, but that could change at any moment. Must be frustrating that management's not "telegraphing" their intentions.
Actually - this is like a "reverse horror movie" where the casket flies open, out jumps Leronlimab which essentially sucks all the money out of its transgressors as they are forced to cover their massive short exposures in a rapidly rising share price environment.
It only takes one startling announcement...and the casket flies open...
(Howl of the wolf in the background)
IMO
Today, to me, represents a potential day of promise...
Not to be "Crass" but leronlimab, in some ways, reflects that promise.
" To remove some of the impediments posed by various conditions/afflictions. "
(In simpler terms - lift burdens = thanks to leronlimab)
Harder some work against it
equals
the less chance they'll ENJOY its
safe
effective
benefits
Ironic...(one of those darn literary terms, Eeeek!)
(IMO)
Well said!
Leronlimab will eventually (unless it is banished by the unscrupulous to preserve their drug lines) effect the lives of everybody directly or indirectly.
A friend just had very expensive "treatments" for lung cancer. He was supposed to have four separate infusions but they had to stop after three - the side effects were so overwhelming. It appears to have "knocked the cancer down - for now." He's very slowly recovering (it's been a few months) and he's still outrageously weak.
I wish Leronlimab had been available, because he may never fully recover from the drug's side effects.
Scenes like this will be the status quo - if Leronlimab is shelved. Except - how did Roger Stone's wife get access?
Hope all know folks in high places to pull some strings or you could end up like my college roommate/good friend.
IMO
C-20 Greetings and Good time to "check up." 13% up was a nice gain. It's still all about the drug >>>>> Leronlimab !
In My Opinion the results of Dr. Recknor's "PASC (- or "Long Haulers," or "Long Covid) results shows that Leronlimab "corrects" a number of "conditions"
[Interesting thought: Correction may not be limited to the "target site" i.e. the virus - further - could THAT be why in the CD10 Mild to Moderate Covid-19 >> the "treatment group" had significantly fewer/less physical problems (sorry the company data is no-more) than the placebo group >>> that's noteworthy! While Leronlimab is addressing the "targeted area" i.e. the virus, it's still flowing and potentially addressing other immunological imbalances and moderating access via CCR5.
Time and again Chronic Inflammation is closely related with many conditions/ailments. From Chronic Kidney Disease, Crohn's Disease, Bladder Cancer, and on and on... chronic inflammation is involved. Anything that "reins-in" chronic inflammation while not doing any harm, has got my attention!
And the Name's >>>>>>" Leronlimab "
"Yep, some call me Pro 140 and others shout out, Hey Vyrologix, Hang in there!"
But then, with a wink and a sly smile whispered, "My friends call me, Leronlimab."
Marvelous stuff - that's why all the "hub bub!"
In my opinion >>> You should check out the results of the CD10 comparing the relative health and adverse stuff between the test group and the placebo group. Also check out the results of the Long Hauler's group results - very impressive. What's also interesting - some of those same "symptoms" are manifest elsewhere...could these be amenable to Leronlimab as well?
Yes, I'm Long
In the absence of new information, nothing has changed except for a strategy of not telegraphing CYDY's next move to the opposition.
News will come, Leronlimab hasn't changed and continues to be surprisingly safe and effective, sounds like the company is re-evaluating "focus" going forward.
We still own the game-changing drug named Leronlimab - I hope the new brain-trust charts an efficient course to success. In the meantime...we've been here before, and survived in spite of the enormous headwinds aimed at CytoDyn.
Ignore the prophecies of DOOM - the good ship CytoDyn sails on with its precious cargo - Leronlimab. It just has a "cheaper entrance point - a bargain price for a GAME-CHANGING DRUG!
IMO
FWIW - This isn't over by a long shot!
Go Leronlimab
Any U S citizens here?
Maybe we should adopt Leronlimab before foreign countries realize Leronlimab's power to make the coronavirus family controllable...think about it.
LERONLIMAB has the potential to be an ECONOMY-SAVER.
Or is the US to play "stupid" as another million are sacrificed on the pyre of greed?
IMO
Thanks enjoyed the post. Leronlimab= Amazing stuff with myriad uses. It's the MOA and its safety that makes it such a "game-changer." It's anti-inflammatory properties and ability to cross the BBB (Blood-brain-barrier) make it, among its numerous other usages, a potent competitor in the most crucial battlefield, the brain. As an "older American" [as, if you're lucky, you will become], it appears there's some similarities in the degradation of one's faculties with age. An immuno-modulating drug such as Leronlimab >>> especially considering its relative safety, would be VERY interesting. [To put it MILDLY!]
It's, indeed, disappointing that more folks don't appreciate the power of leronlimab to affect their lives now, or in the future!
And to "give it away' to those that would "winnow it out"...is disturbing...
IMO
$353,940,426* buys lots of scumbags to do BP's bidding. Allows Aduhelm, Remdesivir, Makena, etc. to go, and remain on market. Nader Pourhassan's transgressions, that are so proudly repeated, were microscopically miniscule in comparison.
His biggest "bad thing" was to bring a life saving drug off the shelf and try to get it approved. BP obviously isn't/wasn't too happy about that.
Sadly, a heroic effort, >> But it still moves forward in spite of the best efforts of Dr. Pourhassan's detractors/adversaries/etc.
$353,940,426 is only the part "on the books"
IMO
United we stay for the right reason -Leronlimab! Been a bit busy lately, but not giving up. The drug is too "special" - don't have too much more to lose anyway...LOL.
Sooner or later the "forces that be" will come under the microscope...they wield too much power, in a land of power-jealousy, and, to top it off, are quite vulnerable. It will be fascinating to watch the confusion - like overturning a large ant hill - as the sycophants, scumbags and flunkies run for cover, stammering, "I didn't know..., had nothing to do with..., etc.
If things like Leronlimab were supported, its value respected and smoothly approved - one might feel differently. Instead of the "respect" Leronlimab deserves, it gets one barrier/insult after another. Sadly, seems it's - the "anything to make a buck," attitude that currently rules!
Over a million dead from Covid and no end in sight...didn't have to be.
(And that's just one of the things that Leronlimab can "handle.")
Million dead means a million families wondering -and it's only a matter of time- just waiting for "the straw that breaks the camel's back," and then the fun begins!
I'll stay supporting Leronlimab, and I'm pleased there are others that feel similarly, because it's the right thing to do.
IMO
https://www.opensecrets.org/federal-lobbying/industries
Guess the tail wags the dog again, and again, and again.
Take a look at the cash being put out by the "top industry" to influence government, agencies, campaigns, etc. Over a third of a billion dollars last year.
And then check this link -
https://www.opensecrets.org/federal-lobbying/industries/summary?cycle=2021&id=H04
Some interesting information - Any wonder why an honest, working drug, like Leronlimab - that could have saved a lot of lives - can't get anywhere in this environment. I guess we should be pleased (?) they've given us remdesivir, aduhelm, makena, etc.
I pay taxes for this? So do you...
IMO
While Lalezari's recording re:CD12 is difficult/impossible to retrieve, here is a letter Dr. Jay Lalezari wrote that covers some of the same material and more...
https://www.reddit.com/r/CYDYFacts/comments/rcot4u/letter_from_dr_jay_lalezari/
Tried the "Wayback Machine" to see if I could extract an archived copy of Dr. Jay's letter. I'm new at this, but it doesn't appear to bring up Jay's tape. Tried to pull up another interesting post by Jay - that too was not possible. Hmmm.
Wayback Machine: https://web.archive.org/
Really hoping you are correct re: herd immunity. But there appear to be "some flies in the ointment!"
In Googling current vaccine status:
At least 254,599,776 people or 77% of the population have received at least one dose.
Overall, 216,690,804 people or 65% of the population are considered fully vaccinated.
Additionally, 96,035,748 people or 29% of the population have received a booster dose.
So approximately 1/3 of the populace is not "fully vaccinated (two doses)"
****
An interesting (sobering) report from California:
COVID-19 deaths in California among vaccinated rose sharply with omicron (vaccination not as formidable in the face of omicron - my note)
2022 March 07
https://www.eastbaytimes.com/2022/03/06/covid-19-deaths-among-vaccinated-rose-sharply-with-omicron/
****
I guess we'll find out. Glad Todos Med. is allowed to market Tollovid. The only truly effective treatments with a decent degree of safety appear to be: Leronlimab, Tollovir (The Tollovids), and to a lesser degree Aviptadil and/or Lenzilumab. Other than the Tollovids - none of these game-changers are available/allowable in the US.
(IMO)
NASH is a "KEY" - the 700 g results are warmly awaited. HIV, which sounded so promising, might not be as meaningful as other labs are talking about a "cure" for HIV.
BUT -"An announcement does not a cure make!"
In the meantime, There is some "mud" in the HIV water. What kind of results did Amarex turn over to CytoDyn. Were they worth the paper they were printed upon? Their sloppy execution does not fill me with anticipatory excitement. The receipt of those on March 3rd - were they a powerful blessing or further proof of Amarex's chicanery?
Finally, I still believe that long covid (PASC) is the best path forward in the absence of any "slam-dunks."
*A definite need
*A strong and growing population of PASC-people
*A first trial with obvious success in numerous areas
*A strong level of support for more leronlimab/PASC trials
*CytoDyn's exploration of PASC does not put it on a collision course with BP. Right now, our covid-cure explorations make us as A GIANT TARGET BULLSEYE, as success could potentially "knock over BP's vaccination/booster cash cow". BP will fight that tooth and nail!
*Trials should be easily filled as there are plenty of folks with PASC
*Trials do not take vast amounts of time to run - How many weeks were used before - was it eight weeks of treatment and is that an adequate amount (I'd defer to Dr. Recknor for that information)?
*Success in addressing the numerous manifestations of PASC give CytoDyn a foot in the door to explore using leronlimab to address associated maladies/afflictions/conditions.
*It's important to mobilize the groups of "PASC people" and keep them informed. Why - We can't allow the FDA to sweep the results generated quietly into a dustbin and discard them. We need a "ground-swell" of support to make sure our results receive an EUA or approval.
*We will also (probably) receive governmental blessing, as folks with PASC are becoming an expensive burden (through no fault of their own).
As long as the corona-virus-family runs rampant - PASC will be an on-going problem. One that is worldwide and, to a large degree, addressable (based on the first trial) by Leronlimab!
Go Leronlimab!!
IMO
Arper, Re: dosage of ivermectin
I am completely reliant on others for ivermectin's appropriate dosage and determination of the point where the dosage is considered toxic. As mentioned previously, not being medically trained - my information is gleaned from various GC presentations and/or information presented/read elsewhere.
In actuality, the rationale presented, explaining the relative "power" of the 3CL protease inhibition offered by different drugs, was instructive and helped explain why ivermectin has now been superseded by preparations with greater powers of 3CL protease inhibition.
So - your post isn't "quibbling" it's "refining the picture."
At the same time, Tollovid/Tollovir's relative safety compared to the other 3CL protease inhibitors, makes (IMO) the choice obvious. The Todos preparations are head and shoulders more preferable.
And just in time...
Omicron BA.2 Variant Now More Than Half Of All New Covid Cases Across Large Swath In U.S., Per CDC
2022 March 22
https://deadline.com/2022/03/omicron-ba-2-half-new-covid-cases-northeast-u-s-1234984127/
"Numbers updated this morning by the CDC indicate that the percentage of new Covid cases across the United States tied to the even more transmissible BA.2 variant has jumped from 23% in early March to 35% this week." But this is an average - some areas are experiencing much higher rates of BA.2.
...And looking around at all the maskless folks rejoicing together in the warming air - we're about to get clobbered. A pleasingly, happy picture with potentially dire consequences. Stay safe!
Sorry the message posted twice...
And the Tollo-family are only one segment of this company - very encouraging
Thank you for good TOMDF wishes. As folks generally luxuriate with the "imaginary Covid-break," BA2 is already here spreading quietly. More transmissible than the original omicron and we'll soon find out its level of severity.
It appears vaccinations and boosters had less success vs the original omicron, compared to earlier variants. I'm concerned that my vacs and boosts might not be enough against BA2, so stocked up on Tollovid.
Hope GC has plenty more Tollovid ready to put out for sale as a "herbal supplement."
I suspect Todos Med. is soon going to find its Tollovid, in growing demand.
Keep in mind (according to my interpretation of what I've read):
A. It's imperative to inhibit the 3CL protease released in the infected cell ASAP as well as protect the invaded cells defenses. It appears The "Tollvid herbal supplement" IS recognized as a 3CL inhibiter.
B. YOU can acquire Tollovid for use at home WITHOUT A PRESCRIPTION
C. Don't expect to get Tollovid if you end up in the hospital...it's not part of the SOC (Standard of Care - the drugs permitted by the FDA for treating severe and critical Covid).
D. Tollovir is not yet accessible, so once in the hospital you'll only receive the SOC approved drugs. Thus far Tollovir has outperformed the SOC in it's two trials. But once in the hospital, your survival will be totally dependent on the efficacy of the SOC.
I think GC is going to sell a lot of Tollovid!
The above is based on my readings and strictly my opinion. It is posted for your entertainment and discussion. It is not to be considered medical advice. For medical advice, kindly consult your physician(s).
Inhibition of the 3CL protease (viral 3-chymotrypsin-like cysteine protease),is a process that interferes with viral replication of corona viruses as well as numerous other viruses.
Ivermectin appears to be a weak 3CL protease inhibiter. It is NOT nearly as strong/effective as Tollovir or Pfizer's Paxlovid. It may have had some beneficial effects on the "original Covid-19 iteration," but newer variants are generating much greater viral loads. Sufficient amounts of ivermectin to address the increased viral loads could easily be toxic.
Unfortunately, Paxlovid includes ritonavir to slow the metabolism, or breakdown, of PF-07321332 to remain active long enough, with concentrations sufficient, to combat the virus. Ritonovir has potentially serious side effects >>> Tollovir does not!
Tollovir appears to be quite effective at squelching viral replication in Covid-19. Further, it has exhibited Immunological benefits as well.
BP might prefer to minimize the focus on effective treatments, as it could interfere with their "gravy-train" of massive yearly vaccine/booster sales world-wide!
But Tollovir is here, shows significant promise and works against all known coronaviruses, regardless of variant.
Unfortunately, the two drugs most effective at saving lives have NOT been approved by the FDA (Challenge >> Google "The FDA's funding" - could this be why effective treatments like Leronlimab and Tollovir have an "uphill battle" getting approval in the US?)
But the good news - we can get Tollovid as an OTC herbal remedy.
I'm distrustful of getting yearly (or more often) vaccinations/boosters fresh out of the lab. I like the idea that Tollovid and the Tollovid(s) are a "herbal remedy" known to Chinese herbalists back into history. It appears to be significantly safer than the latest of BP's anti-virals (Remdesivir, Paxlovid, Molnupiravir).
I think the choice is clear. I also think GC has quite an operation going and I'm impressed with all that's been accomplished.
Don't forget - Tollovid(s), Tollovir are only one of the "irons in the fire."
I think TOMDF is a very good place to be. VERY Surprised it's priced so cheaply.
IMO
Here's a "deeper dive" into the proposed legislation. It's entitled:
"INSIGHTS
SEC Proposes New Short Position Reporting Rules For Investment Managers
March 10, 2022"
Looks like the DOJ and SEC aren't just searching for check bouncers that market spirit catchers from forty years ago, LOL.
Check it out:
https://btlaw.com/en/insights/alerts/2022/sec-proposes-new-short-position-reporting-rules-for-investment-managers
This one goes into a bunch of detail, but in summary:
"The Bigger Picture
The SEC maintains that the information generated by its proposed short-reporting rules would benefit investors and boost the SEC’s market-oversight ability by producing information that is not captured by existing reporting requirements..."
Goes well with the other articles. The increased data collected will allow the SEC and DOJ to pinpoint who, where, when, what, and how. And then it will probably allow some of those "new hires" (120 new attorneys and 900 new agents in the FBI’s White Collar Crime Program) to visit the "Short Arcade" and play fun games of "Wack-A-Mole."
Happy Wacking!!!
IMO
"Proposed New SEC Rule a Likely Tool for Increased Enforcement Against Short Sellers" March 07, 2022.
https://www.natlawreview.com/article/proposed-new-sec-rule-likely-tool-increased-enforcement-against-short-sellers
A few "fun quotes":
"The SEC highlighted the rule’s usefulness in detecting “short and distort” campaigns. These are instances in which an investor shorts a stock and then engages in a campaign to spread unverified bad news about the stock with the objective of panicking other investors into selling their stock to drive the price down. “Short and distort” campaigns are more likely to occur in stocks with lower market capitalizations, therefore it is likely that an individual or entity engaging in such a practice would be required to report their short activity pursuant to the new Proposed Rule 13f-2."
"Department of Justice is also reportedly conducting a wide-ranging investigation into short “spoofing” — whereby heavy volumes of sell orders are sent to exchanges and then cancelled within fractions of a second as a way of manipulating the stock price — and short “scalping,” in which activist short sellers cash out their positions without disclosing it. Information to be collected under Proposed Rule 13f-2 will likely be used by the SEC’s Division of Enforcement to detect this and other sorts of conduct and bring enforcement actions."
"The SEC has noted that publicly releasing aggregated information about large short positions under the proposed rule may, in some instances, increase the risk of trading behavior harmful to short sellers, namely by enabling traders to create a “short squeeze.”"
"...the proposed rule will also add to the SEC’s enforcement arsenal in targeting short sale activity the Commission sees as harmful to the markets."
Looks like these strategies help "put a lid" on those FTD (failure to deliver) problems- losses of vast sums of money. Perhaps the fast and loose" moves are finally being winnowed out!
So how's this going to play out for those working 24/7 to undermine CYDY's progress? Will they get paid for their undermining efforts - or do Ramen noodles loom large in their future?
IMO
CG's transgression in college, doesn't appear to have been ruled a felony...Thank goodness they didn't "bounce a check" in the process! (Some will understand the reference). Gosh, I guess "they had to force the booze on the sorority sisters," not. Where I went undergrad - underage drinking was the norm rather than an aberration.
And now he's all grown up and running a company.
Cute news, but not something overly concerning. Now if we find he was selling spirit catchers - that's a horse of a different color! LOL.
It's interesting the lengths some will go to to undermine others - perhaps they think it somehow "scores them points (?) in the giant scheme of reality? Unfortunately, (probably) most see this as just "petty."
I'm not searching for a saint, but someone that can lead this company to success - and GC appears to be on the right course.
IMO
Commissiong had three videos out today and the news of the 3CL transaction (appearing to be) completed. Can't help but feel positive - especially since there's a shake-up in the whole "addressing Covid-19 in the US" coming. There's a reason almost 1 million people have died here in the US!
Tomorrow should be interesting!
(also agree with GreeseMonkey - those not happy - please grab some hankies and wander elsewhere)
IMO
Muddying water clouds - but DOJ/SEC IS investigating and now the game changes. Schemes including the coordinated short attacks against CYDY have gone without redress...up to now.
The microscope is being aimed and it appears the target(s) are being "reeled in!"
Like the statement "Simply put, naked short selling is one massive embezzlement scheme that for years has mostly gone ignored."
"Naked short selling is among the most fraudulent of schemes. It is the illegal practice of selling shares a short seller has neither borrowed, owns, nor intends to buy, resulting in a “failure to deliver” (FTD) amounting to trillions of dollars in FTDs, as some research indicates."
I guess they are no longer ignore fraud that amounts to TRILLIONS OF DOLLARS!
It's about time.
Help the US Attorney's office get all the "fast and loose" that have battered CYDY. Send a note to the House of Representatives Financial Affairs Committee (Chairman Rep Maxine Waters) so they can pass it along to SEC/DOJ.
Email: FSCDems@mail.house.gov
Subject Line: Attention Chairman Maxine Waters
Seems we at CytoDyn have been on the "receiving end" long enough. Time to Aim the DOJ/SEC cannon at those playing "fast and loose" and impeding Leronlimab's progress!
DOJ probe into shadowy underworld of short selling ‘long overdue’
Interesting article - The implications that the DOJ and SEC are targeting CytoDyn (brought up on this board with the investigation tied to CytoDyn's misdeed(s)??) are misplaced.
https://www.complianceweek.com/risk-management/doj-probe-into-shadowy-underworld-of-short-selling-long-overdue/31237.article
This article (January 11, 2022) is an interesting read.
I like how it compares "naked shorts" to “It’s like xeroxing your car title 100 times and selling that car to 100 people, but you only have one car,” Christian said. “That’s what Wall Street is doing.”
A "real problem that has long gone ignored."
It definitely has affected the fortunes of CytoDyn. Maybe there's a new initiative to go after this kind of manipulation and hang the culprits "out to dry."
IMO
PS two other posts listing just a few of the numerous results of the DOJ/SEC investigations -- see posts # 205198 and #205277 Enjoy!
No questions on my side of the board - if I had Covid and was in trouble - Leronlimab would be my first choice - all four ( or more if necessary) injections, stay away from people until two clear tests then - BINGO done!
Back to work, school, shuffleboard, whatever...
(now this is strictly my opinion not medical advice!)
But we can't access Leronlimab, even though it appears relatively safe, but we can take stuff that has potential nasty side effects.
A strange "side effect" from the CD10 trial (Moderate Covid-19)...the treatment group (with Leronlimmab) SAEs (Serious Adverse Events) were reported lower than the placebo group.
That's Very Nice News - think about what that means,
IMO